Elliott MILLENSON - Far Hills NJ, US Wendy STRONGIN - Far Hills NJ, US Carolyn MILLENSON - Far Hills NJ, US
International Classification:
G01N 33/569 A61B 5/145
US Classification:
435 5, 4352872, 600309
Abstract:
A test device for detecting an analyte in a sample of bodily fluid, includes at least one hollow needle configured to obtain a sample of bodily fluid, an enclosure configured to contain a reagent, a portion configured to open the enclosure, a test results indicator configured to absorb the bodily fluid, the test results indicator including at least one test zone configured to indicate the presence of an analyte in the bodily fluid when the at least one test zone is in fluidic contact with the reagent, a housing, and a cover configured to be movable with respect to the housing between a closed position precluding access to the at least one hollow needle and an open position permitting access to the at least one hollow needle. Additionally, the at least one hollow needle is in fluid communication with the test results indicator.
In late 1987, a company called University Hospital Laboratories, run by businessman Elliott Millenson, submitted an application seeking approval of a rapid home blood test for HIV. In March 1988, however, the FDA declined to accept it for filingthe ministerial act that ordinarily initiates the long